604 related articles for article (PubMed ID: 17202451)
1. A five-gene signature and clinical outcome in non-small-cell lung cancer.
Chen HY; Yu SL; Chen CH; Chang GC; Chen CY; Yuan A; Cheng CL; Wang CH; Terng HJ; Kao SF; Chan WK; Li HN; Liu CC; Singh S; Chen WJ; Chen JJ; Yang PC
N Engl J Med; 2007 Jan; 356(1):11-20. PubMed ID: 17202451
[TBL] [Abstract][Full Text] [Related]
2. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.
Lee ES; Son DS; Kim SH; Lee J; Jo J; Han J; Kim H; Lee HJ; Choi HY; Jung Y; Park M; Lim YS; Kim K; Shim Y; Kim BC; Lee K; Huh N; Ko C; Park K; Lee JW; Choi YS; Kim J
Clin Cancer Res; 2008 Nov; 14(22):7397-404. PubMed ID: 19010856
[TBL] [Abstract][Full Text] [Related]
3. An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.
Roepman P; Jassem J; Smit EF; Muley T; Niklinski J; van de Velde T; Witteveen AT; Rzyman W; Floore A; Burgers S; Giaccone G; Meister M; Dienemann H; Skrzypski M; Kozlowski M; Mooi WJ; van Zandwijk N
Clin Cancer Res; 2009 Jan; 15(1):284-90. PubMed ID: 19118056
[TBL] [Abstract][Full Text] [Related]
4. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
[TBL] [Abstract][Full Text] [Related]
5. A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.
Yanagisawa K; Tomida S; Shimada Y; Yatabe Y; Mitsudomi T; Takahashi T
J Natl Cancer Inst; 2007 Jun; 99(11):858-67. PubMed ID: 17551146
[TBL] [Abstract][Full Text] [Related]
6. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.
Zhu ZH; Sun BY; Ma Y; Shao JY; Long H; Zhang X; Fu JH; Zhang LJ; Su XD; Wu QL; Ling P; Chen M; Xie ZM; Hu Y; Rong TH
J Clin Oncol; 2009 Mar; 27(7):1091-9. PubMed ID: 19188679
[TBL] [Abstract][Full Text] [Related]
7. A four-gene signature from NCI-60 cell line for survival prediction in non-small cell lung cancer.
Hsu YC; Yuan S; Chen HY; Yu SL; Liu CH; Hsu PY; Wu G; Lin CH; Chang GC; Li KC; Yang PC
Clin Cancer Res; 2009 Dec; 15(23):7309-15. PubMed ID: 19920108
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA signature predicts survival and relapse in lung cancer.
Yu SL; Chen HY; Chang GC; Chen CY; Chen HW; Singh S; Cheng CL; Yu CJ; Lee YC; Chen HS; Su TJ; Chiang CC; Li HN; Hong QS; Su HY; Chen CC; Chen WJ; Liu CC; Chan WK; Chen WJ; Li KC; Chen JJ; Yang PC
Cancer Cell; 2008 Jan; 13(1):48-57. PubMed ID: 18167339
[TBL] [Abstract][Full Text] [Related]
9. Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray study.
Blackhall FH; Wigle DA; Jurisica I; Pintilie M; Liu N; Darling G; Johnston MR; Keshavjee S; Waddell T; Winton T; Shepherd FA; Tsao MS
Lung Cancer; 2004 Nov; 46(2):197-204. PubMed ID: 15474668
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism and gene expression of microsomal epoxide hydrolase in non-small cell lung cancer.
Lin TS; Huang HH; Fan YH; Chiou SH; Chow KC
Oncol Rep; 2007 Mar; 17(3):565-72. PubMed ID: 17273734
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
12. Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer.
Baty F; Facompré M; Kaiser S; Schumacher M; Pless M; Bubendorf L; Savic S; Marrer E; Budach W; Buess M; Kehren J; Tamm M; Brutsche MH
Am J Respir Crit Care Med; 2010 Jan; 181(2):181-8. PubMed ID: 19833826
[TBL] [Abstract][Full Text] [Related]
13. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.
Hu Z; Chen X; Zhao Y; Tian T; Jin G; Shu Y; Chen Y; Xu L; Zen K; Zhang C; Shen H
J Clin Oncol; 2010 Apr; 28(10):1721-6. PubMed ID: 20194856
[TBL] [Abstract][Full Text] [Related]
14. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
[TBL] [Abstract][Full Text] [Related]
15. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
16. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
17. Genomic-wide cDNA microarray screening to correlate gene expression profile with chemoresistance in patients with advanced lung cancer.
Oshita F; Ikehara M; Sekiyama A; Hamanaka N; Saito H; Yamada K; Noda K; Kameda Y; Miyagi Y
J Exp Ther Oncol; 2004 Jul; 4(2):155-60. PubMed ID: 15500010
[TBL] [Abstract][Full Text] [Related]
18. Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection.
Broët P; Camilleri-Broët S; Zhang S; Alifano M; Bangarusamy D; Battistella M; Wu Y; Tuefferd M; Régnard JF; Lim E; Tan P; Miller LD
Cancer Res; 2009 Feb; 69(3):1055-62. PubMed ID: 19176396
[TBL] [Abstract][Full Text] [Related]
19. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
[TBL] [Abstract][Full Text] [Related]
20. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
